These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19412825)

  • 21. Serum circulating human mRNA profiling and its utility for oral cancer detection.
    Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
    J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
    Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of papillary thyroid carcinoma with serum protein profile analysis.
    Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
    Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.
    Hu Y; Zhang S; Yu J; Liu J; Zheng S
    Breast; 2005 Aug; 14(4):250-5. PubMed ID: 16085230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
    Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
    Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
    Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.
    Kojima T; Yoshikawa K; Saga S; Yamada T; Kure S; Matsui T; Uemura T; Fujimitsu Y; Sakakibara M; Kodera Y; Kojima H
    J Surg Res; 2009 Jul; 155(1):13-7. PubMed ID: 19394641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
    Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
    Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Using ANN and serum protein pattern models in liver cancer diagnosis].
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):189-92. PubMed ID: 15854466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of SELDI-TOF-MS technology in study of laryngeal carcinoma biomarkers].
    Xu Y; Huangfu H; Wang B; Cheng Y; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 22(18):820-3. PubMed ID: 19166025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of liquid chip-mass spectrometry technology for screening serum biomarker proteins in lung squamous cell carcinoma].
    Bu LN; Yang SY; Du J; Nan YD; Lin XL; Zheng HD; Huo SF; Shang WL; Liu YF
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1662-6. PubMed ID: 19957521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.
    Liu W; Li X; Ding F; Li Y
    Scand J Rheumatol; 2008; 37(2):94-102. PubMed ID: 18415765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of gastric cancer by serum proteomic fingerprinting.
    Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
    Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
    Ervens J; Fuchs H; Niemann VT; Hoffmeister B
    J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.